2010-2020年冰岛孕妇流感疫苗接种情况及孕妇和婴儿流感疾病负担
该回顾性描述性研究纳入2010-2020年十个流感流行季在雷克雅未克Landspitali大学医院接受20周超声检查的孕妇,评估流感疫苗接种率及孕妇和婴儿的流感/流感样疾病负担。孕妇接种率从2011-2012年的6.2%升至2019-2020年的37.5%,孕妇流感/流感样疾病发病率为5.5-22.1/1000人年,估计疫苗效果为34-100%。孕期接种对孕妇(IRR 0.36,95%CI 0.22-0.58)和接种季节的婴儿(IRR 0.40,95%CI 0.17-0.97)有保护作用。
要点
- 孕妇流感疫苗接种率从2011-2012年的6.2%升至2019-2020年的37.5%。
- 孕妇流感/流感样疾病发病率为5.5-22.1/1000人年,婴儿<12月龄为0-13.4/1000人年。
- 孕期接种对孕妇(IRR 0.36,95%CI 0.22-0.58)及接种季节婴儿(IRR 0.40,95%CI 0.17-0.97)有保护作用。
核心结论
- 孕期流感疫苗接种覆盖率不理想,接种对孕妇和接种季节的婴儿提供显著保护,需要采取举措提高孕产妇疫苗接种覆盖率。
研究设计与样本
- 回顾性描述性研究,纳入2010-2020年十个流感流行季在雷克雅未克Landspitali大学医院接受20周超声检查的所有孕妇。
- 疫苗接种和流感/流感样疾病诊断数据来自国家中央数据库。
主要发现
- 孕妇流感疫苗接种率从2011-2012年的6.2%上升至2019-2020年的37.5%。
- 孕妇流感/流感样疾病发病率为5.5-22.1/1000人年,<12月龄婴儿为0-13.4/1000人年。
- 十个流感季节的估计疫苗效果为34-100%。
- 孕期接种对孕妇流感/流感样疾病有保护作用(IRR 0.36,95%CI 0.22-0.58)。
- 孕期接种对接种季节的婴儿有保护作用(IRR 0.40,95%CI 0.17-0.97),对<6月龄婴儿可能也有保护作用(IRR 0.51,95%CI 0.22-1.21)。
临床怎么用
- 原文结论指出需要采取举措提高孕产妇疫苗接种覆盖率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Influenza vaccinations are recommended in pregnancy to protect both the pregnant woman and the unborn baby. The aim of this study was to assess the influenza vaccine uptake among pregnant women in Iceland in ten influenza seasons and to estimate the influenza disease burden on pregnant women and their infants. METHODS: This was a retrospective, descriptive study on influenza vaccine uptake among pregnant women and the burden of influenza and influenza-like illness (ILI) among pregnant women and their infants in ten influenza seasons. All women attending a 20-week ultrasound at Landspitali University Hospital in Reykjavik in August-April each influenza season 2010-2020 were included in the study. Data on influenza vaccinations and influenza/ILI diagnoses was collected from central national databases. RESULTS: The influenza vaccine uptake increased from 6.2 % in 2011-2012 to 37.5 % in 2019-2020. The incidence rate of influenza/ILI among pregnant women ranged from 5.5 to 22.1/1000 person-years. The estimated vaccine effectiveness in the ten influenza seasons was 34-100 %. The incidence rate of influenza/ILI among infants < 12 months of age was 0-13.4/1000 person-years. Influenza vaccinations in pregnancy are protective against influenza/ILI in pregnant women (IRR 0.36, 95 % CI 0.22-0.58), infants in the season of vaccination (IRR 0.40, 95 % CI 0.17-0.97) and probably for infants < 6 months of age (IRR 0.51, 95 % CI 0.22-1.21). CONCLUSIONS: Influenza vaccine coverage in pregnancy is suboptimal. Influenza vaccinations in pregnancy provide significant protection against influenza/ILI for pregnant women and infants in the season of vaccination. Initiatives to improve maternal vaccination coverage are needed.
引用
- Kristinsdottir I, Haraldsson A, Thors V, et al. Influenza vaccination in pregnant women in Iceland 2010-2020 and the burden of influenza in pregnant women and their infants. Vaccine. 2024. PMID: 38413277. doi:10.1016/j.vaccine.2024.02.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。